BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Juvaris BioTherapeutics 

866 Malcolm Road
Suite 100
Burlingame  California  94010  U.S.A.
Phone: 650-259-1800 Fax: 650-697-8828


SEARCH JOBS


Industry
Biotechnology






 Company News
Juvaris BioTherapeutics Announces License to Colby Pharmaceutical for JVRS-100 and CLDC (Cationic Lipid-DNA Complex) Platform for Human Health 9/9/2011 10:40:05 AM    More...
Juvaris BioTherapeutics Announces Publication of Preclinical Anti-Leukemic Effects of JVRS-100 Immunotherapy 9/30/2010 9:58:05 AM    More...
Juvaris BioTherapeutics Completes Second Close on $25 Million Series B Financing 1/27/2010 7:10:05 AM    More...
Juvaris BioTherapeutics Initiates Phase 2 Study of Influenza Vaccine Adjuvant in Elderly Population 11/2/2009 9:57:49 AM    More...
Juvaris BioTherapeutics Announces First Close on $25 Million Series B Financing 9/17/2009 7:09:25 AM    More...
Juvaris BioTherapeutics Announces Strategic Collaboration with Antigen Discovery Inc. 6/29/2009 12:06:23 PM    More...
Juvaris BioTherapeutics' Universal Influenza Vaccine Protects from Lethal H1N1 and H3N2 Challenges in Pre-Clinical Studies 5/8/2009 9:16:28 AM    More...
Juvaris BioTherapeutics' Vaccine Adjuvant, JVRS-100, Generates Superior T-Cell Mediated Immune Responses to Influenza in Clinical Trial 4/27/2009 10:24:09 AM    More...
Juvaris BioTherapeutics Announces Progress in Alliance with Bayer Animal Health 1/9/2009 9:50:18 AM    More...
Juvaris BioTherapeutics Announces Positive Data from Clinical Trial of JVRS-100 Adjuvanted Flu Vaccine 1/8/2009 9:31:45 AM    More...
1234

//-->